Aimei HealthAFJK.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Aimei Health (AFJK.O) trades at a P/E of 94.00x, P/B of 4.86x, P/S of N/A, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 72nd percentile over the trailing 10Y window (vs. 72nd percentile over 3Y); P/B sits at the 44th percentile over the trailing 10Y window (vs. 44th percentile over 3Y); P/S historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data).
Cross-sectional valuation: its P/E ranks at the 94th percentile within its industry and the 93rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 168.14%, ranking at the 92nd percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 27.9 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. Aimei Health operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: AFJK · AFJK
Want the full picture on whether Aimei Health (AFJK.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 94.00 | ||||||
| P/B (MRQ) | 4.86 | ||||||
| P/S (TTM) | N/A | — | — | — | — | — | — |
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 168.14% |